Cellares
Biotech · Healthcare
Cellares extends Series D to $277M as ARK Invest joins syndicate
June 9, 2026$277M · Series D
Cell therapy manufacturing startup Cellares has expanded its Series D round to $277 million after a new $20 million investment from Cathie Wood’s ARK Invest.
Lead Investors
ARK InvestBlackRockEclipse VenturesT. Rowe Price Investment ManagementBaillie Gifford
Read the Full Story in Velocity
Get curated startup and tech news with new stories published daily, company insights, and real-time alerts.